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ABSTRACT
Expression of human mitochondrial DNA is indis-
pensable for proper function of the oxidative phos-
phorylation machinery. The mitochondrial genome
encodes 22 tRNAs, 2 rRNAs and 11 mRNAs and their
post-transcriptional modification constitutes one of
the key regulatory steps during mitochondrial gene
expression. Cytosine-5 methylation (m5C) has been
detected in mitochondrial transcriptome, however
its biogenesis has not been investigated in details.
Mammalian NOP2/Sun RNA Methyltransferase Fam-
ily Member 2 (NSUN2) has been characterized as an
RNA methyltransferase introducing m5C in nuclear-
encoded tRNAs, mRNAs and microRNAs and as-
sociated with cell proliferation and differentiation,
with pathogenic variants in NSUN2 being linked to
neurodevelopmental disorders. Here we employ spa-
tially restricted proximity labelling and immunode-
tection to demonstrate that NSUN2 is imported into
the matrix of mammalian mitochondria. Using three
genetic models for NSUN2 inactivation––knockout
mice, patient-derived fibroblasts and CRISPR/Cas9
knockout in human cells––we show that NSUN2 is
necessary for the generation of m5C at positions 48,
49 and 50 of several mammalian mitochondrial tR-
NAs. Finally, we show that inactivation of NSUN2
does not have a profound effect on mitochondrial
tRNA stability and oxidative phosphorylation in dif-
ferentiated cells. We discuss the importance of the
newly discovered function of NSUN2 in the context
of human disease.
INTRODUCTION
Mammalian mitochondria contain small semi-
independent, multi-copy genome referred to as mtDNA,
which encode the key subunits of the oxidative phos-
phorylation (OXPHOS) system. The concerted action of
both ∼90 nuclear-encoded proteins and 13 mitochondrial-
encoded proteins is required to form five OXPHOS enzyme
complexes and consequently for the synthesis of adenosine
triphosphate (ATP). In addition to the mRNAs coding for
13 proteins of the OXPHOS system, the human mtDNA
also encodes 2 mitochondrial (mt-) rRNAs and a complete
set of 22 mt-tRNAs, required for intramitochondrial
protein synthesis. An additional 200–300 mammalian
nuclear-encoded genes are involved in mtDNA mainte-
nance, in various steps of mitochondrial transcription and
protein synthesis and assembly of the respiratory chain
complexes (1).
Universally, RNA molecules undergo multiple post-
transcriptional modifications, which are crucial for their
biogenesis and/or function. The mitochondrially-encoded
tRNAs also undergo extensive post-transcriptional matu-
ration, by nuclear-encoded proteins imported from the cy-
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tosol, including chemical nucleotide modifications, CCA
addition at the 3′ end and deadenylation (2,3). Recent data
suggest that over 7% of all mt-tRNA residues in mammals
undergo post-transcriptionalmodification, with over 30 dif-
ferent modified mt-tRNA positions so far described (4).
The nucleotide modifications of mt-tRNA play a role in de-
coding, tRNA structural stability and aminoacylation (5).
Cytosine-5 methylation (m5C) is a common epigenetic
modification found in DNA where it plays important reg-
ulatory roles in transcription (6). Also in RNA m5C is,
together with m6A and pseudouridine, one of the most
abundant post-transcriptional modifications (7,8). Several
enzymes responsible for m5C RNA modifications have
been identified. With the exception of DNA methyltrans-
ferase 2 (Dnmt2), which catalyses m5C formation of po-
sition C38 of cytoplasmic (cyto-) tRNAAsp, tRNAVal and
tRNAGly (9,10), all known m5C RNA methyltransferases
are members of the highly conserved NOL1/NOP2/Sun
(NSUN) domain containing family. NSUN1 and NSUN5
are involved in m5C modification of rRNAs for cytoplas-
mic ribosomes (11,12), while cytoplasmic tRNACys and
tRNAThr (position 72) are the substrates of NSUN6 (13).
Two NSUN family members are imported and function in
mitochondria. NSUN4 methylates mitochondrial 12S mt-
rRNA and plays a role in mitochondrial ribosome biogen-
esis (14). Furthermore, our group and others have demon-
strated that NSUN3 is responsible for methylation of po-
sition C34 of mt-tRNAMet (15–17), which is further oxi-
dized to 5-formylcytosine by AlkBH1 (17,18). NSUN2 is
a well-characterized RNA methyltransferase, responsible
for cytosine-5 methylation (m5C) of tRNALeu(CAA) at posi-
tion C34 and C40 of tRNAGly, at C48 and 49 of tRNAAsp,
tRNAVal and tRNAGly and at C50 of tRNAGly (19,20). In
addition to cytoplasmic tRNAs this protein also methylates
a variety of cytoplasmic mRNAs (21) and vault non-coding
RNAs that can function as microRNAs (22).
Recent data indicate that defects in the nucleotide mod-
ification of mt-tRNA can lead to human disorders of mi-
tochondrial respiration (2,23–25). The m5C modification
in the variable-loop (V-loop) region has been detected in
bovine and human mt-RNAs (5). However, the biogenesis
of this mitochondrial m5C has not been investigated. Here,
we demonstrate that NSUN2, which previously has only
been associated with the modification of extramitochon-
drial RNA, is partially localized in the mitochondrial ma-
trix and is responsible for methylation of tRNA positions
48, 49 and 50 in the V-loop region of six human and eight
mouse mt-tRNA. Although ablation of NSUN2 results in
undetectable levels of mt-tRNAm5C, the lack of this modi-
fication does not appear to have any substantial effect on
mammalian mitochondrial function. Taken together, this
work demonstrates that, in addition to its role in the modi-
fication of nuclear-encoded RNA, NSUN2 is also responsi-
ble for the majority of m5C modifications of mt-tRNAs in
mouse and human.
MATERIALS AND METHODS
Animals and housing
All animal experiments were carried out in accordance
with the UK Animals (Scientific Procedures) Act 1986
(UK Home Office license: PPL70/7538, PPL80/2231 and
PPL80/2619) and EUDirective 2010/63/EU. The NSUN2
knockout mice generated as described previously (26) were
housed in the Wellcome Trust––Medical Research Council
Cambridge Stem Cell Institute Animal Unit.
Maintenance and transfection of mammalian cell lines
All cells were grown at 37◦C in a humidified atmosphere
with 5% CO2 in high-glucose DMEM (Gibco) supple-
mented with 10% foetal bovine serum (Gibco).
The Flp-In T-Rex HEK293T cell line was used
to generate a doxycycline-inducible expression of
NSUN2.FLAG.STREP2. The full-length NSUN2 cDNA
construct was cloned into a pcDNA5/FRT/TO plasmid
encoding FLAG.STREP2-tag as previously described (27).
The oligonucleotides used for cloning can be found in Sup-
plementary Table S1. Cells were grown in the same medium
described above, supplemented with selective antibiotics
hygromycin (100 g/ml) and blasticidin (15 g/ml). For
transient complementation of U2OS NSUN2 KO cells
were transfected with 0.8 g of NSUN2.FLAG.STREP2
construct with Lipofectamin 2000 (Invitrogen). Medium
was replaced after 24 h and cells were analysed after 48 h.
Genome editing by CRISPR/Cas9
To generate NSUN2 knockout in human cells, a pair of
gRNAs against NSUN2 (Supplementary Table S1) were
cloned in All-in-One-GFP plasmid as described in Chiang
et al. (28). The plasmid was transfected into human os-
teosarcoma U-2 (U2OS) cells by electroporation using the
Neon Transfection System (Life Technologies) according
to the manufacturer’s instructions. Twenty four hours af-
ter transfection, cells were FACS-sorted based on EGFP
expression and plated to obtain individual clones. NSUN2
KO clones were analysed by PCR and Sanger sequencing
to detect NHEJ-related nuclear genome edits, RT-qPCR
(using SYBR Green Master Mix (Applied Biosystems)
with 100 ng cDNA input) to analyse steady-state levels
of NSUN2 mRNA (Supplementary Table S2) and western
blotting to examine NSUN2 protein levels (Supplementary
Figure S1).
Spatially restricted proximity labelling and MS analysis
For subcellular proteome mapping, we prepared sev-
eral HEK293 cell lines stably expressing various sub-
mitochondrially localized constructs of APEX2. The spe-
cific sub-mitochondrial localization was achieved by fus-
ing APEX2 to a well-characterized targeting signal di-
recting it to the mitochondrial matrix (MLATRVFS-
LVGKRAISTSVCVRAH from cytochrome c oxidase sub-
unit 4 isoform 1 (29) (Mito-APEX2), a protein localized
in intermembrane space––SCO1 (IMM-APEX2), or a pro-
tein localized in outer mitochondrial membrane––TOM20
(OMM-APEX2). The cytosol-localized APEX2 (Cyto-
APEX2) was included as additional control. These con-
structs have been described previously (30). HEK293 cells
were cultured in T75 flasks and expression of genetically
targeted sub-mitochondrial APEX2 (matrix, IMS-, OMM-
APEX2) and APEX2-NES was induced by doxycycline
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(100 ng/ml) overnight. Next, we incubated the cells with
desthiobiotin-phenol (DBP, 250 M) for 30 min at 37◦C,
followed by 1 min incubation with 1 mMH2O2 to generate
the DBP radical in situ (31). After labelling, the cells were
lysed with 2% SDS in 1× TBS (25 mM Tris, 0.15 M NaCl,
pH 7.2) lysis buffer and DBP-labelled peptides were en-
riched by streptavidin and analysed by LC–MS/MS (Sup-
plementary Figure S2).
Analytical capillary columns (100 cm × 75 m i.d.) and
trap columns (2 cm × 150 m i.d.) were packed in-house
with 3 m Jupiter C18 particles (Phenomenex). The long
analytical column was placed in a column heater (Analyti-
cal Sales and Services, Pompton Plains, NJ, USA) regulated
to a temperature of 45◦C. Dionex Ultimate 3000 RSLC
nano-system (Thermo Scientific) was operated at a flow
rate of 350 nl/min over 2 h with linear gradient ranging
from 95% solvent A (H2O with 0.1% formic acid) to 40%
of solvent B (acetonitrile with 0.1% formic acid). The en-
riched samples were analysed on an Orbitrap Fusion Lu-
mos mass spectrometer (Thermo Scientific) equipped with
an in-house customized nanoelectrospray ion source. Pre-
cursor ions were acquired (m/z 300–1500 at 120 K resolv-
ing power and the isolation of precursor for MS/MS analy-
sis was performed with a 1.4 Th. Higher-energy collisional
dissociation (HCD) with 30% collision energy was used for
sequencing with a target value of 1e5 ions determined by
automatic gain control. Resolving power for acquired MS2
spectra was set to 30k at m/z 200 with 150 ms maximum
injection time.
All MS/MS data were searched by MaxQuant (version
1.5.3.30) with Andromeda search engine at 10 ppm precur-
sor ion mass tolerance against the SwissProt Homo sapi-
ens proteome database (20199 entries, UniProt (http://www.
uniprot.org/)). The following search parameters were ap-
plied: tryptic digestion, fixed carbaminomethylation on cys-
teine, dynamic oxidation of methionine, DBP (331.190) la-
bels of tyrosine residue. The false discovery rate (FDR) was
set at<1% for peptide spectrummatch including unlabelled
peptides. FDR <1% was obtained for unique labelled pep-
tide and unique labelled protein level as well.
Cell fractionation
HEK293T cells were cultured in DMEM supplemented
with 10% FBS. Detached cells were washed twice with PBS
and resuspended in homogenization buffer containingman-
nitol (Sigma Aldrich) (0.6 M), Tris (10 mM), EDTA (0.1
mM) (pH 7.4) and protease inhibitors (Roche). Cells were
homogenized with a glass Dounce homogenizer. Next, dif-
ferential centrifugation was used to obtain the different cell
fractions (1000 × g for 10 min to remove cell debris and
nuclei, next for 10 min at 10 000 × g to pellet the mito-
chondria). The pellet containing the mitochondrial frac-
tions was resuspended in 50 mMTris–HCl, pH 7.4 with 150
mMNaCl and divided in four fractions of which three were
used for treatment with Proteinase K (NEB). Proteinase K
treatment was performed under different stringencies: 0.2
g/5 mg for 10 min, 2 g/5 mg for 20 min and 20 g/5 mg
mitochondrial proteins for 30 min.
Immunodetection of proteins
The intracellular localization of NSUN2 by immunofluo-
rescence in fixed human osteosarcoma 143B cells was per-
formed as described previously (32). The following anti-
bodies were used: rabbit anti-TOM20 (Santa Cruz Biotech-
nology, sc-1145, 1:200), rat anti-HA (Roche, 118667431001,
1:200), Alexa Fluor 594 anti-rabbit (1:1000, ab150088, Ab-
cam), Alexa Fluor 488 anti rat (Abcam, ab150157, 1:1000),
mouse anti-FLAG (Sigma, F1084, 1:500). Immunofluores-
ence images were captured using a Zeiss LSM880 confocal
microscope and processed using ImageJ.
For western blot analysis, 10–30 g of extracted pro-
teins were loaded on SDS-PAGE 4–12% bis–tris gels (Life
Technologies) and transferred onto amembrane using iBlot
2 Dry Blotting System (Thermo Fisher Scientific). The
following antibodies were used: rabbit anti-NSUN2 (Pro-
teintech, 20854-1-AP, 1:1000), mouse anti-Tubulin (Sigma
Aldrich, T9026, 1:5000), mouse anti-TOM22 (Abcam,
ab10436, 1:2000), mouse anti-GAPDH (Abcam, ab9484,
1:5000) mouse anti-FLAG (Sigma, F3165, 1:1000), mouse
anti-mtSSB1 (a kind gift of Prof. D. Kang, 1:4000),
total OXPHOS Mouse WB antibody cocktail (Abcam,
ab110412, 1:2000) and mouse anti-HSC70 (Santa Cruz
Biotechnology sc7298, 1:10 000).
Mitochondrial DNA copy number analysis
Total cellular DNAwas isolated frommouse liver and heart
tissue. Tissue was cut into little pieces in medium (pH 7.4)
containing 0.32 M sucrose, 10 mM Tris–HCl pH 7.4 and
1 mM EDTA and homogenized. DNA was extracted us-
ing a DNeasy Blood and Tissue kit (Qiagen) according
to the manufacturer’s recommendations. Copy numbers of
mtDNA were measured by quantitative PCR according to
the manufacturer’s recommendations and using PowerUp
SYBR Green Master Mix (Applied Biosystems). Primer
and probe sequences can be found in Supplementary Table
S2.
RNA analysis by northern blot
RNA was extracted with TRIzol reagent (Thermo Fisher
Scientific). Total RNA was resolved on 1% agarose gels
containing 0.7M formaldehyde in 1× MOPS buffer (mt-
mRNAs) or on 10% UREA–PAGE (mt-tRNAs), trans-
ferred to a nylon membrane, ultraviolet-crosslinked to the
membrane and hybridized with radioactively labelled T7-
transcribed radioactive RNA-probes.
RNA bisulfite sequencing
RNA was extracted with TRIzol reagent (Thermo Fisher
Scientific) and treated with TURBO DNase (Ambion) ac-
cording to manufacturer’s instructions. Bisulfite conversion
of 2 g DNase treated RNA was performed using the
Methylamp One-Step DNA modification kit (Epigentek).
The reaction mixture was incubated for three cycles of 90◦C
for 5 min and 60◦C for 1 h. Following desalting with Micro
Bio-spin 6 chromatography columns (Bio-Rad) twice, RNA
was desulfonated by adding an equal volume of 1 M Tris
(pH 9.0) and incubated for 1 h at 37◦C. For whole genome
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sequencing of mouse RNA, a library was generated with
Truseq Small RNA Library Preparation kit (Illumina) ac-
cording to the manufacturer’s protocol. Alternatively, re-
verse transcriptionwas performedwith specific primers (Su-
perscript III, Life technologies). After the first stage PCR
with overhang primers (Supplementary Table S2), excess
primers were removed with Ampure XP beads. An 8 cycles
second round PCR was performed with indexed primers
(Nextera XT), followed by another clean-up with Ampure
XP beads. Quality and concentration were assessed with a
D1000 Screentape for TapeStation (Agilent Genomics). Li-
braries were subjected to high-throughput sequencing using
the IlluminaMiSeq platform. After quality trimming and 3′
end adaptor clipping with Trim Galore!, reads longer than
20 nt were aligned to a computationally bisulfite-converted
human reference genome (GRCh38) with Bismark (33).
RESULTS
A proportion of NSUN2 localizes inside human mitochondria
In order to obtain data on the subcellular localization of
endogenous NSUN2 in human cells, we conducted spa-
tially restricted proximity labelling experiments (34). We
targetedAPEX2 to four different subcellular compartments
of HEK293 cells: mitochondrial matrix (using the mito-
chondrial targeting sequence of cytochrome c oxidase fused
to APEX2: Matrix-APEX2), the mitochondrial intermem-
brane space (using SCO1 fused to APEX2: IMS-APEX2),
outer-mitochondrial membrane (using TOM20 fused to
APEX2: OMM- APEX2) and the cytosol (using a nu-
clear export signal, NES, fused to APEX2: Cyto-APEX2)
(Figure 1A) (30). Within these subcellular localizations,
we found that endogenous NSUN2 was reproducibly la-
belled by matrix-APEX2, while other APEX2 constructs
showed no labelling on this protein (Figure 1B).Directmass
spectrometric (MS) analysis detected the desthiobiotin-
phenol (DBP)-labelled tyrosine site (Y646) of NSUN2 in
the Matrix-APEX2 experiment (Figure 1C). Given that the
in situ generated phenoxyl radical by Matrix-APEX2 can-
not cross the inner-mitochondrial membrane due to its
short lifetime, this latter result suggests amitochondrialma-
trix localization of endogenous NSUN2 (31,35).
In order to provide further evidence for mitochondrial
localization of NSUN2, an HA-tagged version of the
NSUN2 protein (GenBank: NM 017755.6) was transiently
expressed in human osteosarcoma cells. Immunofluores-
cence analysis showed a variation in the cellular localiza-
tion of the NSUN2 protein. In a predominant subset of
cells, NSUN2 could be detected in the nucleus or in the nu-
cleus and cytoplasm (Figure 2A), consistent with previously
published data (36). However, a subgroup of cells existed
with predominant cytoplasmic localization of NSUN2, in
which a proportion of NSUN2 co-localized with the mi-
tochondrial protein TOM20 (Figure 2B, inset). To pro-
vide additional confirmation for mitochondrial localization
of the NSUN2 protein, we performed cellular fractiona-
tion experiments ofHEK293T cells inducibly expressing the
NSUN2.FLAG.STREP2 construct followed by detection
of the expressed protein by western blotting (Figure 2C).
A proportion of the NSUN2.FLAG.STREP2 protein was
detected in the mitochondrial fraction, along with a known
mitochondrial matrix protein, mtSSB1. Both NSUN2 and
mtSSB1 were resistant to proteinase K treatment of the mi-
tochondrial fraction, consistent with NSUN2 being present
within the mitochondria in human cells. Taken together,
these results imply that, in addition to the cell nucleus, a
proportion of NSUN2 localizes inside mitochondria.
Mouse NSUN2 methylates mitochondrial tRNA at positions
48–50
Having shown mitochondrial localization of the NSUN2
protein, we set out to determine whether inactivation of
its expression affects m5C methylation of mtRNA. To this
end we analysed m5C methylation in mouse mtRNA iso-
lated from NSUN2-null mice (NSUN2 –/–) (26), or con-
trol animals, using high-throughput sequencing of cDNA
libraries obtained after bisulfite treatment of RNA. The
bisulfite RNA sequencing (BS RNA-Seq) analysis of to-
tal RNA isolated from the liver of NSUN2 –/– mice and
age-matched wild type mice revealed a strong, general re-
duction of the m5C signal for mtRNA in the NSUN2 mu-
tants (Figure 3A). More detailed inspection revealed that
m5C signal reduction in the NSUN2 –/– samples corre-
sponded mostly to the mt-tRNA-specific reads, with not
statistically significant signal reduction for mt-mRNA se-
quences (Figure 3B). It should be noted, however, that m5C
methylation levels in mt-mRNA are generally very low in
our and previous studies (37) and that not all mRNAs
are fully covered in this dataset. Consequently, although
we do not observe a significant difference in mt-mRNA
methylation levels in NSUN2–/– mice as compared to WT
animals, we cannot rule out that NSUN2 methylates mt-
mRNA in addition to mt-tRNA. We next examined the to-
tal mt-tRNA pool for the tRNA positions affected by the
lack of NSUN2. The methylation of the variable loop (V-
loop), in particular positions 48, 49 and 50, was reduced,
while the methylation within the anticodon loop, remained
unaffected (Figure 3C). Since some mt-tRNAs were in-
sufficiently covered in this dataset, we also used targeted
resequencing of bisulfite treated RNA samples to exam-
ine whether NSUN2 is responsible for methylation of mt-
tRNAs that have at a cytosine in position 48, 49 or 50. First
we analysed mouse mt-tRNAMet which contains two m5C
modifications, positions C34 (wobble base, mtDNA posi-
tion m.3875) and C48 (V- loop, mtDNA position m.3888)
(Figure 4A). The BS RNA-Seq analysis revealed that the
mt-tRNAMet wobble base C34 is not affected by the lack of
NSUN2, consistent with the previous reports on NSUN3
being responsible for modifying this base (15–17). On the
contrary, methylation levels of position C48, which is al-
most fully methylated in wild-type mouse tissue, were re-
duced to background levels in the NSUN2 –/– mice sam-
ples (Figure 4B and C). Next, we studied m5C methyla-
tion in other mouse mt-tRNAs that contain cytosines in
the V-loop region, namely mt-tRNALeu(UUR) (C48), mt-
tRNAHis (C48), mt-tRNAAsn (C48), mt-tRNATyr (C48),
mt-tRNAGlu (C49), mt-tRNALeu(CUN) (C48 and C49) and
mt-tRNASer(AGY) (C49 and C50) (Figure 4D–I). The BS
RNA-Seq analysis confirmed that cytosines at position 48
or 49 in mt-tRNALeu(UUR), mt-tRNAHis, mt-tRNAAsn or
mt-tRNATyr and mt-tRNAGlu are methylated by NSUN2
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Figure 1. Proximity labelling reveals mitochondrial matrix pool of NSUN2. (A) Scheme of compartment-specific APEX2 labelling (Matrix, IMS, OMM
and cytosol). (B) Mass spectrometry signal intensity of APEX2-labelled NSUN2 peptides from four subcellular APEX2 constructs. (C) MS/MS spec-
trum of NSUN2 DBP-peptide (KLSSETYSQAK; DBP-modified Y underlined) labelled by mitochondrial matrix-targeted APEX2. More details and an
additional spectrum (for LAQEGIYTLYPFINSR) in given in Supplementary Figure S2.
(Figure 4D and E). In the case of murine mt-tRNALeu(CUN),
which contains two cytosines in the V-loop region (C48
and C49), position 48 and 49 are methylated in a NSUN2-
dependent manner to ∼5% and 50%, respectively, (Figure
4F and G). Also, in the case of murine mt-tRNASer(AGY)
which contains two cytosines in the V-loop region (C49
and C50) only position 49 is substantially methylated by
NSUN2 (Figure 4H and I). This is somewhat similar to
the m5C profile detected for the bovine tRNASer(AGY) which
contains three cytosines in the V-loop region (C48–50), with
only C49 being m5C modified. Taken together these data
show that ablation of mouse NSUN2 results in substantial
loss of m5C in the V-loop region of eight mt-tRNAs, consis-
tent with this protein being responsible for the introduction
of this modification.
Human NSUN2 methylates mitochondrial tRNAs at posi-
tions 48–50
Next, we intended to verify whether human NSUN2 is
also responsible for methylation of mt-tRNA. To this end
we performed targeted BS RNA-Seq using RNA isolated
from primary fibroblasts from a patient harbouring a ho-
mozygous splice mutation in the NSUN2 gene and that
lacks a functionalNSUN2 protein (NSUN2mut/mut) (38).
We used RNA from a healthy control (WT) and fibrob-
lasts from a patient carrying loss-of-function mutations in
NSUN3 (NSUN3 mut/mut) (15) as controls. We analysed
six mt-tRNAs that contain at least one cytosine in the V-
loop region, namelymt-tRNATyr (C48),mt-tRNAHis (C48),
mt-tRNALeu(UUR) (C48), mt-tRNAPhe (C48), mt-tRNAGlu
(C49) and mt-tRNASer(AGY) (C48, C49 and C50) using BS
RNA-Seq. This experiment revealed that m5C in the V-
loop region of all six was decreased to background levels
in NSUN2 mutant fibroblasts, but remained unaffected in
the controls (Figure 5A–D). Of note, similarly to bovine
mt-tRNASer(AGY) the human counterpart contains three cy-
tosines in the V-loop region (C48–50) (Figure 5C and D).
However, in contrast to bovinemt-tRNASer(AGY) which con-
tains only m5C49 (4), in human mt-tRNASer(AGY) all three
positions are modified by NSUN2. None of the V-loop po-
sitions in humanmt-tRNAwere dependent onNSUN3pre-
viously shown to introduce m5C34 in human mt-tRNAMet,
indicative for non-redundant roles for these mitochondrial
tRNA m5C methyltransferases (Figure 5E and F).
To corroborate these results, we have generated an
NSUN2 CRISPR/Cas9 knock-out cell line using hu-
man U-2 osteosarcoma (U2OS) cell line (NSUN2 KO)
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Figure 2. A subset of NSUN2 protein localizes in the mitochondria. (A, B) Immunofluorescence labelling of a HA-tagged NSUN2 construct (green) in
osteosarcoma 143B cells. Cells were counterstained for the mitochondrial import receptor subunit TOM20 (red) and DAPI (blue). Scale bar: 10 M.
NSUN2 localizes mainly to the nucleus (A). A fraction of the NSUN2 protein co-localizes with the mitochondria (B). (C) Sub-cellular localization of a
FLAG-tagged NSUN2 construct analysed by western blotting with antibodies against FLAG, TOM22 (mitochondrial outer membrane), mtSSB1 (mito-
chondrial matrix) and GAPDH (cytosol). HEK293T cells were fractionated into debris (‘D’), cytosol (‘C’) and mitochondria. ‘T’ indicates the total cell
lysate.
(Supplementary Figure S1). Firstly, we confirmed the
lack of detectable m5C in the mt-tRNA V-loop region
of mt-tRNALeu(UUR) (C48), mt-tRNAHis (C48), and mt-
tRNASer(AGY) (C48, C49 and C50) in the knock-out cells
(Figure 6). Next, we set out to complement the NSUN2 de-
fect by re-expressing the Flag-tagged version of theNSUN2
(NSUN2KO+NSUN2-FLAG) that partially localises into
human mitochondria (Figure 2). Transient expression of
NSUN2.FLAG.STREP2 in the NSUN2 KO human cells
resulted in partial restoration of m5C in mt-tRNA (Fig-
ure 6A-C). These results support the dependency of the
mt-tRNA V-loop region m5C on NSUN2 and, impor-
tantly, strengthens the notion that the NSUN2 isoform en-
coded by the main splice mRNA splice variant (GenBank:
NM 017755.6) is localized inside human mitochondria. In
summary, our data show that inactivation of NSUN2 in
mammalian species (mouse and man) results in the loss of
the m5C modification in the V-loop region of mt-tRNAs,
consistent with the mitochondrial localization of a pool of
the NSUN2 protein.
Mitochondrial function upon inactivation of NSUN2
In the next set of experiments, we asked whether ablation of
NSUN2 affects mitochondrial function in vivo in a mouse
model through its impact on mitochondrial gene expres-
sion. NSUN2 knock-out mice are viable, but appreciably
smaller than their wild-type and heterozygous littermates,
with males being sterile and both genders showing cyclic
alopecia (26) and brain development disorders (39). Firstly,
we checked whether the absence of NSUN2 in mice af-
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Figure 3. Lack of NSUN2 in mouse affects mt-RNA cytosine methylation. (A–C) Whole genome sequencing of bisulfite treated RNA isolated from liver
tissue from NSUN2 –/– and WT mice. (A) Total mitochondrial RNA cytosine methylation in WT and NSUN2 –/– mouse liver tissue. (B) Cytosine
methylation of mitochondrial tRNA and mRNA in WT and NSUN2 –/– mice. For (A) and (B), the boxes represent 1SD above and below the mean of
the data. Student’s t test. (C) Mean cytosine methylation level of the mt-tRNA pool for each position of the mt-tRNA (according to the universal tRNA
position) for WT and NSUN2 –/– mice.
fects mtDNA copy number. We analysed mtDNA copy
number by qPCR in liver and heart tissue from NSUN2
knock out (NSUN2 –/–) mice and age-matched wild type
control tissue, however, no significant difference was mea-
sured (Figure 7A). In order to investigate the effect of the
lack of NSUN2 on the stability of mt-tRNAs, we per-
formed northern blot analysis using mouse RNA isolated
from liver and heart (Figure 7B and C). We found no sig-
nificant differences in the steady-state levels of mouse mi-
tochondrial NSUN2-targets (mt-tRNAGlu, mt-tRNAHis or
mt-tRNASer(AGY)) as compared to mt-tRNALys, which has
no cytosine in the V-loop region, hence is not a substrate of
NSUN2. These results indicate that methylation of the V-
loop region in mt-tRNAs by NSUN2 is not crucial for the
stability of the mt-tRNAs, consistent with the existing data
for cyto-tRNAs. Despite the normal steady-state levels of
mt-RNA in NSUN2 –/– animals, their function could be
perturbed by the lack of m5C in the V-loop region impact-
ing intra-mitochondrial translation and consequently OX-
PHOS complex assembly and function. To address this, we
analysed a variety of proteins of the OXPHOS system in the
NSUN2 –/– mice by western blot. We compared heart and
liver tissue of NSUN2 –/– animals with wild type mice and
did not detect any appreciable differences in steady-state
levels of OXPHOS complex proteins (Figure 7D). Taken to-
gether, our data indicate that the lack of m5C in the V-loop
region does not have any profound effect on mitochondrial
function.
DISCUSSION
Recent years have witnessed a rapid improvement in our
understanding of how the expression of mtDNA-encoded
genes is regulated both in human health and in disease
states (2,3). Dysfunction of mitochondrial gene expression,
caused by mutations in either the mitochondrial or nu-
clear genomes, is associated with a diverse group of human
disorders characterized by impaired mitochondrial respira-
tion. Within this group, an increasing number of mutations
have been identified in nuclear genes involved in mtRNA
epitranscriptome shaping (15,40–49). Furthermore, there is
increasing evidence that some of the most common het-
eroplasmic pathogenic mtDNA mutations perturb the in-
troduction of mt-tRNA post-transcriptional modifications
(16,50,51). Lastly, a number of mtRNAmodifying enzymes
have been identified and characterized using basic molecu-
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Figure 4. NSUN2 methylates positions C48-49 of mitochondrial tRNA in mouse. (A–I) Cytosine methylation of mouse liver mt-tRNAs. Throughout the
figure green indicates methylated cytosines, while unmodified cytosines are shown in grey. (A) Schematic structure of mt-tRNAMet and the position of
m5C (green circle) in the anticodon loop and variable loop. (B) Summary of the BS RNA-Seq results for mt-tRNAMet in WT and NSUN2 –/– mouse
liver. (C) Heatmaps of BS RNA-Seq reads for mt-tRNAMet for WT and NSUN2 –/– showing cytosines of individual reads (on y-axis). (D) Schematic
structure of mt-tRNALeu(UUR), mt-tRNAHis, mt-tRNAAsn, mt-tRNATyr and mt-tRNAGlu, indicating the position of m5C (green circle). (E) Summary of
the BS RNA-Seq results for mt-tRNALeu(UUR), mt-tRNAHis, mt-tRNAAsn, mt-tRNATyr and mt-tRNAGlu of WT and NSUN2 –/– mouse liver tissue. (F)
Schematic structure of mt-tRNALeu(CUN), indicating the position of m5C (green circle). (G) Summary of the BS RNA-Seq results for mt-tRNALeu(CUN)
of WT and NSUN2 –/– mouse liver tissue. (H) Schematic structure of mt-tRNASer(AGY), indicating the position of m5C (green circle). (I) Summary of the
BS RNA-Seq results for for mt-tRNASer(AGY) in WT and NSUN2 –/– mouse liver tissue.
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Figure 5. HumanNSUN2methylates mitochondrial tRNA postions 48–50. (A–F) Cytosine methylation of mt-tRNA of human fibroblasts. (A) Schematic
structure of mt-tRNATyr, mt-tRNAHis, mt-tRNALeu(UUR), mt-tRNAPhe and mt-tRNAGlu. The green circles depict the positions of m5C in V-loop. (B)
Summary of the BS RNA-Seq results for WT, NSUN2-null (NSUN2 mut/mut) and NSUN3-null (NSUN3 mut/mut) patient fibroblasts. (C) Schematic
structure of mt-tRNASer(AGY) and the positions of m5C (green circles) in V-loop. (D) Summary of the BS RNA-Seq results for mt-tRNASer(AGY) for WT
fibroblasts, NSUN2 mut/mut and NSUN3 mut/mut. (E) Schematic structure of mt-tRNAMet and the position of the precursor m5C (green circle) at
position 34. (F) Summary of the BS RNA-Seq results for mt-tRNAMet for WT fibroblasts, NSUN2 mut/mut and NSUN3 mut/mut.
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Figure 6. Transient expression of NSUN2 partially restores m5C in mt-tRNA. (A–C) Targeted BS RNA-Seq after transient expression of a
NSUN2.FLAG.STREP2 construct in human NSUN2 KO cells. (A) Methylated cytosines of mt-tRNAHis. (B) Methylated cytosines of mt-tRNALeu(UUR).
(C) Methylated cytosines of mt-tRNASer(AGY). The methylation levels have been adjusted to the percentage of the NSUN2.FLAG.STREP2 transfected
cells (Supplementary Figure S3).
lar and systems biology approaches (25,52–56). Despite this
recent progress several mitochondrial RNA modifications,
including m5C, await the responsible enzyme to be identi-
fied.
The NSUN2 protein has been reported to introduce m5C
in several nuclear-encoded transcripts, including the V-loop
and wobble position of tRNA, mRNAs, microRNAs and
vault noncoding RNAs. In this work we showed mito-
chondrial localization of NSUN2. Given its wide range
of targets in cytoplasmic RNA, we investigated whether
NSUN2 also methylates mtRNA. Our experimental work
has revealed several NSUN2-dependent targets in mtDNA-
encoded mammalian tRNAs localized in the V-loop region
(positions 48, 49, 50). The m5C modification is most of-
ten found at positions 48 and 49 of the V-loop, located
between the anticodon arm and the T-arm. Methylation
at these positions on the nucleobase does not directly in-
terfere with Watson–Crick base pairing, however its pres-
ence has been demonstrated to contribute to tRNA stabil-
ity and protein synthesis (20). C48 has been shown to con-
tribute to tRNA folding through the formation of a reverse
Watson–Crick base pair with G15 in the D-loop, with one
of these residues often modified to further stabilize the in-
teraction (57). In the case of m5C, the contribution of the
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Figure 7. Mitochondrial function upon inactivation of NSUN2. (A) mtDNA copy number determination by qPCR of mtDNA relative to the nuclear
RNase P gene in liver and heart of WT and NSUN2 –/– mice. qPCR was performed in triplicate and error bars indicate the s.d. of the mean. (B) Northern
blot analysis of three mt-tRNAs that are modified by NSUN2 (mt-tRNAGlu, mt-tRNAHis and mt-tRNASer(AGY) in WT and NSUN2 –/– liver and heart
tissue. Mt-tRNALys, which is not methylated by NSUN2, is used as a loading control. (C) Quantification of the band intensities shown in B. (D) Western
blot analysis of liver and heart for NDUFB8, SDHB, UQCRC2, MTCO1, ATP5A. HSC70 was used as loading control.
methyl group is not yet fully understood, but it may aid base
stacking through increasing the hydrophobicity of the nu-
cleobase, and/or promote Mg2+ binding which in turn in-
creases stability (58). Previously published data showed that
the stability of mammalian cytoplasmic tRNA decreases
when NSUN2 and Dnmt2 are absent in mice (20,59). How-
ever, there is no evidence that loss of NSUN2 alone re-
duces the abundance of these cyto-tRNAs (39). Our anal-
ysis of mt-tRNAs modified by NSUN2 in the tissues from
the NSUN2 –/– mouse also did not reveal any substantial
changes in their stability. This suggests that, similar to cyto-
tRNAs, the lack of the V-loop m5C alone is not sufficient to
destabilize tRNA.More detailed analysis will be required to
establish the mitochondrial function of NSUN2. However,
it is worth noting that the mechanism of how V-loop nu-
cleotides contribute to mt-tRNA folding may be different
as compared to cyto-tRNA. Enzymatic and chemical prob-
ing of bovine mt-tRNAPhe have suggested that these tRNAs
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primarily rely on interactions between the D-stem and V-
loop in order to achieve the L-shaped tertiary structure re-
quired (60), as the majority of mammalian mt-tRNAs lack
the conserved residues, particularly G18, G19, 55, and
C56, that are required for the stabilizing D-loop/T-loop in-
teraction in cyto-tRNA.
Mutations in the NSUN2 gene have been associated with
neurodevelopmental disorders in humans. Martinez et al.
(38) and Abbasi-Moheb et al. (61) reported several fam-
ilies harbouring homozygous splice or stop mutations in
NSUN2 presenting with Dubowitz-like syndrome charac-
terized by the constellation of mild microcephaly, intellec-
tual disability, growth retardation, facial dysmorphism and
muscular hypertonia. Furthermore, Khan et al. (62) re-
ported a family with three affected children carrying a ho-
mozygous missense variant causing a mutation at a con-
served residue (p.Gly679Arg) presenting with spasticity,
ataxic gait, increase of liver enzymes and creatine phospho-
kinase in addition to dysmorphisms and developmental de-
lay. The overall phenotype of the Dubowitz-like syndrome
patients reported by Martinez et al. and Abbasi-Moheb et
al. cannot be specifically linked to mitochondrial disorders,
nevertheless brain abnormalities, including microcephaly,
have been commonly reported in bone fide mitochondrial
respiratory chain disorders (15,63–65). On the other hand,
the phenotypes found in the family harbouring the mis-
sense NSUN2 variant reported by Khan et al. could, in
principle, be considered as typical for mitochondrial dis-
ease (66). However, without further research it is impossible
to postulate which of these potentially mitochondrial phe-
notypic features are specifically caused by NSUN2-related
defect in methylation of mitochondrial RNA. Careful fol-
low up studies of the mitochondrial molecular features
(mtRNA transcriptome and epitranscriptome) and mito-
chondrial OXPHOS function (e.g. plasma lactate levels or
TCA intermediates) in the reported and any future NSUN2
cases could be considered in the view of our discovery of a
mitochondrial function for NSUN2.
Our results imply that the lack of m5C in the V-loop re-
gion due to ablation of NSUN2 does not have any profound
effect on mitochondrial function in differentiated cells.
Based on previous studies in a mouse model, NSUN2 has
been implicated in skin, germ cell and neural differentiation
(26,39,67,68). The mitochondrial OXPHOS is crucial in the
differentiation process (69,70). We speculate that in patients
that carry a mutation in the NSUN2 gene or in NSUN2
mouse knockout models, the aberrant modification of mt-
tRNA could affect translation of mitochondrially-encoded
proteins, perturbing the energymetabolism needed in differ-
entiating cells. Therefore, future research on the mitochon-
drial function ofNSUN2 could focus on early stages of neu-
ral development.
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